Revelation Biosciences, Inc.
REVB· Nasdaq
Revelation Biosciences, Inc.
- Last sale
- Sep 17, 2026 · -1.99%
- Market cap
- $3.79M
- 3.98M shares
- Filings
- 387
Price
Sep 17, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $4,063,857 | reported | |
| FY 2024 | 2024-12-31 | $3,548,996 | reported | |
| FY 2023 | 2023-12-31 | $4,145,902 | reported | |
| FY 2022 | 2022-12-31 | $5,377,400 | reported | |
| FY 2021 | 2021-12-31 | $6,914,756 | reported |
Revelation Biosciences, Inc. · CIK 1810560 · Engraved from SEC EDGAR
